FDUS Stock Analysis: Fidus Investment | NASDAQ
Asset Management | NASDAQ, USA | Market Cap: 743m USD | 12M Return: 4.6% | US3165001070 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 6.27M
EPS Trend: -90.7%
Qual. Beats: 0
Rev. Trend: 81.3%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.6 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Fidus Investment Corporation (NASDAQ: FDUS) is a Business Development Company (BDC) that provides financing solutions to lower middle market businesses in the United States. As a BDC, the company operates under the Investment Company Act of 1940 and is structured to channel capital to private, small and mid-sized enterprises that often have limited access to traditional bank financing.
Fidus focuses on leveraged buyouts, refinancings, recapitalizations, strategic acquisitions, growth capital, and business expansion transactions. It does not invest in turnarounds or distressed situations. Its debt instruments include subordinated and second lien loans, senior secured and unitranche debt, junior secured loans, and senior subordinated notes, while its equity-oriented investments consist of preferred equity and warrants. The company typically invests between $5 million and $30 million per transaction, with debt investments generally ranging from $5 million to $15 million.
The companys investment focus spans a diverse range of industries, including aerospace and defense, business services, consumer products and retail, food and beverage, healthcare, industrial products and services, information technology, niche manufacturing, transportation and logistics, and value-added distribution. Fidus generally targets US-based companies with annual revenues between $10 million and $150 million and annual EBITDA between $5 million and $30 million.
In conjunction with its financing activities, Fidus typically seeks to acquire minority equity stakes and board observation rights, allowing it to maintain oversight while supporting portfolio company growth.
- Net interest income expands as floating-rate debt assets reprice higher
- Non-accruals and credit losses rise on lower middle market borrower stress
- Deployment pace in unitranche loans drives NAV and dividend coverage
| Net Income: 77.3m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.06 > 0.02 and ΔFCF/TA -0.90 > 1.0 |
| NWC/Revenue: 120.4% < 20% (prev 48.15%; Δ 72.24% < -1%) |
| CFO/TA -0.13 > 3% & CFO -198.3m > Net Income 77.3m |
| Net Debt (105.1m) to EBITDA (106.0m): 0.99 < 3 |
| Current Ratio: 6.41 > 1.5 & < 3 |
| Outstanding Shares: last quarter (38.0m) vs 12m ago 7.96% < -2% |
| Gross Margin: 73.60% > 18% (prev 79.16%; Δ -5.56% > 0.5%) |
| Asset Turnover: 10.71% > 50% (prev 9.34%; Δ 1.37% > 0%) |
| Interest Coverage Ratio: 2.90 > 6 (EBIT TTM 103.1m / Interest Expense TTM 35.5m) |
| A: 0.12 (Total Current Assets 210.7m - Total Current Liabilities 32.8m) / Total Assets 1.50b |
| B: 0.06 (Retained Earnings 97.1m / Total Assets 1.50b) |
| C: 0.07 (EBIT TTM 103.1m / Avg Total Assets 1.38b) |
| D: 0.97 (Book Value of Equity 738.5m / Total Liabilities 762.6m) |
| Altman-Z'' = 2.51 = A |
As of September 21, 2026, the stock is trading at USD 19.36 with a total of 290,803 shares traded. Over the past week, the price has changed by +1.16%, over one month by +1.47%, over three months by +7.88% and over the past year by +4.62%.
Current recommended Stop Loss: 18.90 (which is 2.4% or 1.6 ATR below the current price).
Fidus Investment has received a consensus analysts rating of 4.25. Therefore, it is recommended to buy FDUS.
- StrongBuy: 2
- Buy: 1
- Hold: 1
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 21.5 | 11.1% |
P/E Trailing = 9.4541
P/E Forward = 9.99
P/S = 4.3581
P/B = 1.0063
P/EG = 3.5213
Revenue TTM = 147.7m USD
EBIT TTM = 103.1m USD
EBITDA TTM = 106.0m USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = 288.1m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 105.1m USD (calculated: Debt 288.1m - CCE 182.9m)
Enterprise Value = 847.9m USD (742.8m + Debt 288.1m - CCE 182.9m)
Interest Coverage Ratio = 2.90 (Ebit TTM 103.1m / Interest Expense TTM 35.5m)
EV/FCF = 9.38x (Enterprise Value 847.9m / FCF TTM 90.4m)
FCF Yield = 10.66% (FCF TTM 90.4m / Enterprise Value 847.9m)
FCF Margin = 61.19% (FCF TTM 90.4m / Revenue TTM 147.7m)
Net Margin = 52.34% (Net Income TTM 77.3m / Revenue TTM 147.7m)
Gross Margin = 73.60% ((Revenue TTM 147.7m - Cost of Revenue TTM 39.0m) / Revenue TTM)
Gross Margin QoQ = 76.25% (prev 67.40%)
Tobins Q-Ratio = 0.56 (Enterprise Value 847.9m / Total Assets 1.50b)
Interest Expense / Debt = 12.32% (Interest Expense 35.5m / Debt 288.1m)
Taxrate = 5.82% (4.77m / 82.1m)
NOPAT = 97.1m (EBIT 103.1m * (1 - 5.82%))
Current Ratio = 5.05 (Total Current Assets 210.7m / Total Current Liabilities 41.7m)
Debt / Equity = 0.39 (Debt 288.1m / totalStockholderEquity, last quarter 738.5m)
Debt / EBITDA = 0.99 (Net Debt 105.1m / EBITDA 106.0m)
Debt / FCF = 1.16 (Net Debt 105.1m / FCF TTM 90.4m)
Total Stockholder Equity = 733.4m (last 4 quarters mean from totalStockholderEquity)
RoA = 5.60% (Net Income 77.3m / Total Assets 1.50b)
RoE = 10.54% (Net Income TTM 77.3m / Total Stockholder Equity 733.4m)
RoCE = 7.02% (EBIT 103.1m / Capital Employed (Total Assets 1.50b - Current Liab 32.8m))
RoIC = 6.51% (NOPAT 97.1m / Invested Capital 1.49b)
WACC = 9.09% (E(742.8m)/V(1.03b) * Re(8.11%) + D(288.1m)/V(1.03b) * Rd(12.32%) * (1-Tc(0.06)))
Discount Rate = 8.11% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 98.85 | Cagr: 9.76%
[DCF] Terminal Value 73.42% ; FCFF base≈89.1m ; Y1≈92.3m ; Y5≈104.0m
[DCF] Fair Price = 34.83 (EV 1.43b - Net Debt 105.1m = Equity 1.32b / Shares 38.0m; r=9.09% [WACC]; 5y FCF grow 3.81% → 2.50% )
EPS Correlation: -90.70 | EPS CAGR: -6.48% | SUE: 0.0 | # QB: 0
Revenue Correlation: 81.33 | Revenue CAGR: 10.27% | SUE: 0.68 | # QB: 0
EPS current Quarter (2026-09-30): EPS=0.51 | Chg30d=+0.79% | Revisions=+40% | Analysts=5
EPS current Year (2026-12-31): EPS=2.13 | Chg30d=+0.47% | Revisions=+12% | GrowthEPS=+0.1% | GrowthRev=+16.0%
EPS next Year (2027-12-31): EPS=1.97 | Chg30d=+0.92% | Revisions=+38% | GrowthEPS=-7.4% | GrowthRev=+2.0%
[Analyst] Revisions Ratio: +40% (up=9, down=3)